Select Page

Why are we masking? Are face masks increasing rates of asymptomatic infection? Is asymptomatic infection able to provide immunity?
Join our Grand Rounds Sept. 15 to hear from Dr. Monica Gandhi from UCSF on the importance of masking and its impact on asymptomatic infection rates as well as from Dr. Bryan McVerry who will summarize the REMAP trial and our REMAP protocol and Dr. David Nace who will summarize our SNF strategy, outcomes and implementation of state grant funding.

Department of Medicine Grand Rounds
September 15, 2020

Reasons for Facial Masking for COVID-19: Transmission, Severity of Disease and Immunity

Introduction
Mark Gladwin, MD, Professor and Chair, Department of Medicine

1:50
“Reasons for Facial Masking for COVID-19:  Transmission, Severity of Disease and Immunity”
Monica Gandhi, MD, MPH, Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco

30:08
Summary of REMAP Trial

Bryan McVerry, MD, Associate Professor of Medicine, Division of PACCM
University of Pittsburgh

41:50
Summary of SNF strategy, outcomes and implementation of state grant funding
David Nace, MD, MPH, Associate Professor of Medicine, Division of Geriatrics
University of Pittsburgh

View Presentation  |  CME Module